Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

[Efficacy and availability of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy].

Iijima M, Koike H, Sobue G.

Nihon Rinsho. 2012 Apr;70(4):715-21. Review. Japanese.

PMID:
22568158
2.

Polymorphism of transient axonal glycoprotein-1 in chronic inflammatory demyelinating polyneuropathy.

Iijima M, Koike H, Katsuno M, Sobue G.

J Peripher Nerv Syst. 2011 Jun;16 Suppl 1:52-5. doi: 10.1111/j.1529-8027.2011.00308.x.

PMID:
21696500
3.

[Therapeutic strategy for CIDP (chronic inflammatory demyelinating polyneuropathy)].

Iijima M, Koike H, Sobue G.

Nihon Rinsho. 2013 May;71(5):855-60. Review. Japanese.

PMID:
23777094
4.

Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP.

Iijima M, Tomita M, Morozumi S, Kawagashira Y, Nakamura T, Koike H, Katsuno M, Hattori N, Tanaka F, Yamamoto M, Sobue G.

Neurology. 2009 Oct 27;73(17):1348-52. doi: 10.1212/WNL.0b013e3181bd1139. Epub 2009 Sep 23.

PMID:
19776380
5.

[Treatment options for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)].

Kuntzer T.

Rev Neurol (Paris). 2006 Apr;162(4):539-43. Review. French.

PMID:
16585918
6.

Current treatments of chronic immune-mediated demyelinating polyneuropathies.

Brannagan TH 3rd.

Muscle Nerve. 2009 May;39(5):563-78. doi: 10.1002/mus.21277. Review.

PMID:
19301378
7.

Changes in serum macrophage-related factors in patients with chronic inflammatory demyelinating polyneuropathy caused by intravenous immunoglobulin therapy.

Ochi K, Kohriyama T, Higaki M, Ikeda J, Harada A, Nakamura S.

J Neurol Sci. 2003 Apr 15;208(1-2):43-50.

PMID:
12639724
8.

Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.

Boërio D, Créange A, Hogrel JY, Guéguen A, Bertrand D, Lefaucheur JP.

J Neurol Sci. 2010 May 15;292(1-2):63-71. doi: 10.1016/j.jns.2010.02.002. Epub 2010 Mar 10.

PMID:
20219211
9.

Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: the ICE trial.

Hughes RA.

Expert Rev Neurother. 2009 Jun;9(6):789-95. doi: 10.1586/ern.09.30. Review.

PMID:
19496683
10.

[Therapeutic responsiveness in chronic inflammatory demyelinating polyradiculoneuropathy].

Iijima M.

Rinsho Shinkeigaku. 2011 Nov;51(11):1012-4. Japanese.

PMID:
22277461
11.

Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy.

Tackenberg B, Nimmerjahn F, Lünemann JD.

J Clin Immunol. 2010 May;30 Suppl 1:S65-9. doi: 10.1007/s10875-010-9398-1. Review.

PMID:
20424898
12.

Chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: treatment update.

Nobile-Orazio E, Gallia F, Tuccillo F, Terenghi F.

Curr Opin Neurol. 2010 Oct;23(5):519-23. doi: 10.1097/WCO.0b013e32833dd218. Review. Erratum in: Curr Opin Neurol. 2011 Apr;24(2):191.

PMID:
20689427
13.

Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy.

Lee DH, Linker RA, Paulus W, Schneider-Gold C, Chan A, Gold R.

Muscle Nerve. 2008 Mar;37(3):406-9.

PMID:
17918749
14.

Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.

Nobile-Orazio E, Cocito D, Jann S, Uncini A, Beghi E, Messina P, Antonini G, Fazio R, Gallia F, Schenone A, Francia A, Pareyson D, Santoro L, Tamburin S, Macchia R, Cavaletti G, Giannini F, Sabatelli M; IMC Trial Group.

Lancet Neurol. 2012 Jun;11(6):493-502. doi: 10.1016/S1474-4422(12)70093-5. Epub 2012 May 10.

PMID:
22578914
15.

[Intermittent intravenous immunoglobulin infusion prevented relapses in patients with remission-exacerbation type chronic inflammatory demyelinating polyradiculoneuropathy].

Kanda F, Sekiguchi K, Oishi K, Hamaguchi H, Mitsui S, Kobessho H, Higuchi M, Shirafuji T, Ishihara H.

Rinsho Shinkeigaku. 2006 Mar;46(3):236-8. Japanese.

PMID:
16642939
16.

IVIG regulates BAFF expression in patients with chronic inflammatory demyelinating polyneuropathy (CIDP).

Ritter C, Förster D, Albrecht P, Hartung HP, Kieseier BC, Lehmann HC.

J Neuroimmunol. 2014 Sep 15;274(1-2):225-9. doi: 10.1016/j.jneuroim.2014.06.007. Epub 2014 Jun 19.

PMID:
25002077
17.
18.

Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.

Cocito D, Ciaramitaro P, Isoardo G, Barbero P, Migliaretti G, Pipieri A, Proto G, Quadri R, Bergamasco B, Durelli L.

J Neurol. 2002 Jun;249(6):719-22.

PMID:
12111305
19.
20.

A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg.

Caro XJ, Winter EF, Dumas AJ.

Rheumatology (Oxford). 2008 Feb;47(2):208-11. doi: 10.1093/rheumatology/kem345.

PMID:
18208823

Supplemental Content

Support Center